Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 5 clinical trials
Role of Inflammasomes in COVID-19 Disease

As of March 25, 2020, 414,179 cases and 18,440 deaths secondary to Coronavirus 2019 disease (COVID-19) have been reported worldwide. The unfavorable course of the patients is characterized on the immunological level by an intense pro-inflammatory response which can go as far as a cytokinic storm. This pandemic affects a …

  • 0 views
  • 16 Feb, 2024
  • 2 locations
Targeting Risk Factors for Diabetes in Subjects With Normal Blood Cholesterol Using Omega-3 Fatty Acids

Every 3 minutes a new case of diabetes is diagnosed in Canada, mostly type 2 diabetes (T2D) increasing the risk for heart disease. T2D and heart disease share many common risk factors such as aging, obesity and unhealthy lifestyle. Paradoxically however, while lowering blood LDL, commonly known as "bad cholesterol", …

body mass index
insulin sensitivity/resistance
fish oil
heart disease
fatty acids
  • 0 views
  • 05 Aug, 2020
COVID-19: Study of INFLAmmasome and PLAtelets Functions

COVID-19 pandemic is a severe viral sepsis characterized by the occurrence of Acute respiratory distress syndrome (ARDS) whose pathophysiology is little described

respiratory distress
inflammasome
viraemia
covid-19
acute respiratory distress
  • 0 views
  • 05 Aug, 2020
Biomarkers in Rheumatoid Arthritis Treated With Anti-interleukin-6 Therapy

Some other experimental biomarkers are totally or partially independent of IL-6, or even of inflammasome, and thus are credible candidates for the follow-up of patients treated with anti-IL-6 therapy. Here investigators propose a controlled, prospective, monocentric, observational study evaluating several biomarkers, usual and experimental, in patients suffering from rheumatoid arthritis …

steroidal anti-inflammatory drugs
immunosuppressive agents
inflammatory disorder
arthritis
rheumatism
  • 0 views
  • 16 Feb, 2024
  • 1 location
Change of NLRP3 Inflammasome Expression Level Symptoms and Functional Status in HFpEF Patients Treated With ARNI

But there is no study reported the relationship between NLRP3 inflammasome and HFpEF. In this study, investigators propose a scientific hypothesis that the expression of NLRP3 inflammasome is elevated in patients with HFpEF, and the level of TNF, IL-1 and NLRP3 inflammasome is lower in patients treated with sacubitril/valsartan.

diastolic dysfunction
heart disease
sacubitril
ntprobnp
ejection fraction
  • 0 views
  • 16 Feb, 2024
  • 1 location